NCT01514331

Brief Summary

The main purpose of this study is to investigate effects of SIMV+VG (synchronized intermittent mandatory ventilation+volume guarantee) or PSV+VG (pressure support ventilation+volume guarantee) ventilation on vital signs, patient - mechanical ventilation synchrony, ventilation parameters and inflammatory mediators in neonates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2011

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
22 days until next milestone

First Posted

Study publicly available on registry

January 23, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 20, 2013

Status Verified

November 1, 2013

Enrollment Period

1.8 years

First QC Date

December 20, 2011

Last Update Submit

November 19, 2013

Conditions

Keywords

Ventilator Induced Lung InjuryNeonatal respiratory distressMechanical ventilation

Outcome Measures

Primary Outcomes (13)

  • IL-1beta levels in tracheal aspirate material

    Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported

    Baseline and 72 hours of mechanical ventilation

  • IL-6 level in tracheal aspirate

    Tracheal aspirate will be analyzed for IL6 level and the change from baseline will be reported

    Baseline and 72 hours of mechanical ventilation

  • IL-8 in tracheal aspirate material

    Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported

    Baseline and 72 hours of mechanical ventilation

  • IL-10 level in tracheal aspirate material

    Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported

    Baseline and 72 hours of mechanical ventilation

  • TNF alfa in tracheal aspirate material

    Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported

    Baseline and 72 hours of mechanical ventilation

  • tidal volume variability

    variability in tidal volume measured with babyview program

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • peak inspiratory pressure variability

    variability in peak inspiratory pressure measured with babyview program

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • respiratory rate variability

    changes in respiratory rate, tacypnea rate

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • oxygen saturation variability

    changes in oxygen saturation, desaturation rate, hyperoxy rate

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • lowest carbondioxide level (mmHg)

    ratio of hypocarbic blood gases and least pCo2 level

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • highest carbondioxide level (mmHg)

    ratio of hypercarbic blood gases and highest pCo2 level

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • lowest oxygen level (mmHg)

    ratio of hypoxic blood gases and least pO2 level

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

  • highest oxygen level (mmHg)

    ratio of hyperoxic blood gases and highest pO2 level

    72 hours of mechanical ventilation or entire ventilation time if extubated earlier

Secondary Outcomes (8)

  • bronchopulmonary dysplasia

    36 weeks corrected age

  • patent ductus arteriosus

    in the first week of post natal life of the patient

  • necrotizing enterocolitis

    36 weeks corrected age

  • intraventricular hemorrhage

    during first week

  • pneumothorax

    during first 3 days

  • +3 more secondary outcomes

Study Arms (2)

PSV+VG

ACTIVE COMPARATOR

Neonates who require mechanical ventilation and randomised to pressure support + volume guarantee (PSV+VG) mode

Other: PSV+VG (pressure support ventilation+volume guarantee)

SIMV+VG

ACTIVE COMPARATOR

Neonates who require mechanical ventilation and randomised to synchronised intermittant mandatory ventilation + volume guarantee (SIMV+VG) mode

Other: SIMV+VG mode of ventilation (synchronized intermittent mandatory ventilation+volume guarantee)

Interventions

Neonates who need mechanical ventilation will be ventilated with SIMV+VG mode

Also known as: SIMV + VG mode of ventilation
SIMV+VG

Neonates who need mechanical ventilation will be ventilated with PSV+VG

Also known as: PSV+ VG mode of ventilation
PSV+VG

Eligibility Criteria

AgeUp to 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • neonates with respiratory distress who need mechanical ventilation
  • gestational age less than or equal to 37 weeks
  • neonates who need mechanical ventilation within first 24 hours

You may not qualify if:

  • neonates who need mechanical ventilation other than conventional ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Hospital, Department of Pediatrics, Division of Newborn Medicine

Beşevler, Ankara, 06500, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary AtelectasisVentilator-Induced Lung Injury

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesLung Injury

Study Officials

  • Ebru N Ergenekon, MD

    Gazi University, Division of newborn Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr

Study Record Dates

First Submitted

December 20, 2011

First Posted

January 23, 2012

Study Start

January 1, 2012

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

November 20, 2013

Record last verified: 2013-11

Locations